Company Overview
Snapshot
Founded in December 2005, AsMedic operates with 1–10 employees. The company has secured $500,000 in total capital across one funding round from one investor. AsMedic's platform technology, designed to ensure efficient and personalized drug therapy for asthma, is currently in the Alpha product stage.
Business overview
AsMedic develops solutions for asthma treatment, focusing on the dynamic relationship between airway obstruction and optimal drug dosage. Its core technology is a platform designed to ensure efficient and personalized drug therapy by delivering preplanned dosages into the lungs. This approach allows patients to control lung deposition and bioavailability, aiming to improve therapy control and reduce side effects of inhaled steroids. The company operates within the Health Tech & Life Sciences sector, specifically targeting the Pharma & Medical Biotechnology and Medical Devices industries, with a focus on drug delivery and medical treatment & therapeutics for patients globally.
Log in to access full profile ›Company Intelligence Q&A
- What is AsMedic's primary focus in healthcare?
- AsMedic focuses on developing solutions for asthma treatment, specifically addressing the relationship between airway obstruction levels and the correct drug dosage. Its platform technology aims to provide efficient and personalized drug therapy by delivering optimal preplanned dosages into the lungs.
- What is the key benefit of AsMedic's platform technology?
- The key benefit of AsMedic's platform technology is its ability to facilitate varied drug dosages, allowing patients to control lung deposition and bioavailability. This is designed to improve therapy control and significantly decrease the side effects associated with inhaled steroids.
- What product stage is AsMedic currently in?
- AsMedic's product, POD, is currently in the Alpha stage of development, as of November 2014 when it received funding from a pharmaceutical company.
- Which markets does AsMedic target?
- AsMedic targets the global market, focusing on patients within the Healthcare & Life Sciences sector, specifically in areas of Pharma & Medical Biotechnology and Medical Devices.
- What is AsMedic's total capital raised and number of funding rounds?
- AsMedic has raised $500,000 in total capital across one funding round. This funding was secured in November 2014 from a pharmaceutical company.